Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

by admin | 4月 29, 2020 | 西醫臨床科硏實證

類型: 連結
作者: Yeming Wang et al.
出處: The Lancet
連結: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext#%20

← Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Remdesivir: Drug has 'clear-cut 'power to fight coronavirus →